POKAZANIYa K KhIRURGIChESKOMU LEChENIYu PRI GEPATOTsELLYuLYaRNOY KARTsINOME


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In most countries worldwide, morbidity and mortality from primary malignant liver tumors are increased; hepatocellular carcinoma (HCC) is diagnosed in more than 90% of patients. In compliance with the Milan criteria, the liver resection remains the main treatment of HCC, with a hope of satisfactory long-term results. The preservation of the liver function is important, because the frequency of concomitant liver cirrhosis in patients with HCC is 80%. In recent years, due to best surgical practice and improvement of postoperative management of patients, mortality after liver resection for HCC is less than about 9%, and 5-year survival rate is 37%. Nevertheless, the problem is especially acute for volume of liver resection, depending on the extent of tumor and the stage of concomitant hepatic cirrhosis

Full Text

Restricted Access

References

  1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
  2. IARC. 2011; http://www-dep.iarc.fr/
  3. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2008 г. // Вестник РОНЦ. 2010. Т. 21. № 2.
  4. Barbara L., Benzi G., Gaiani S., et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumour growth rate and patient survival. Hepatology 1992; 16: 132-76.
  5. Nagasue N., Kohno H., Chang Y.C., et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993; 217: 375-84.
  6. Oka H., Kurioka N., Kim N., et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680-87.
  7. Poon R.T., Fan S.T., Lo C.M., et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 2002; 236: 602-11.
  8. Zhou X.D., Tang Z.Y., Yang B.H., et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001; 91: 1479-86.
  9. Nathan H., Schulick R.D., Choti M.A., Pawlik T.M. Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 2009; 249: 799-805.
  10. Omata M. APASL working committee meeting consensus on HCC., APASL February 13-16, 2009, Hong Kong.
  11. NCCN Clinical Practice Guidelines in Oncology. Hepatobiliary Cancer. 2012.
  12. Esnaola N.F., Mirza N., Lauwers G.Y., et al. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg 2003; 238(5): 711-19.
  13. Grazi G.L., Ercolani G., Pierangeli F., et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 20011; 234(1): 71-8.
  14. Poon R.T., Fan S.T., Lo C.M., et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001; 234(1): 63-70.
  15. Tateishi R., Yoshida H., Shiina S., et al. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut 2005; 54(3): 419-25.
  16. Capussotti L., Ferrero A., Vigano L., Polastri R., Tabone M. Liver resection for HCC with cirrhosis: Surgical perspectives out of EASL/AASLD guidelines. EJSO 2009; 35: 11-5.
  17. Minagawa M., Makuuchi M., Takayama T., Ohtomo K. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001; 233: 379-84.
  18. Ikai I., Arii S., Okazaki M., et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 200 7: 3 7: 676-91.
  19. Sun C. Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol 2007; 96: 37-45.
  20. Kobayashi S., Takahachi S., Kato Y., et al. Surgical treatment of lymph node metastases from hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2011; 18(4): 559-66.
  21. Okuda H. Hepatocellular carcinoma development in cirrhosis. Res Clin Gastroenter 2007; 1: 161-73.
  22. Grazi G.L., Cescon M., Ravaioli M., et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for longterm survival and tumour recurrence in a single centre. Aliment Pharmacol Ther 2003; 17: 119-29.
  23. John A.R., Khan S., Mirza D.F., et al. Multivariate and univariate analysis of prognostic factors following resection in HCC: the Birmingham experience. Dig Surg 2006; 23: 103-9.
  24. Teh S.H., Christein J., Donohue J., et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage live disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005; 9: 1207-15.
  25. Nadig D.E., Wade T.P., Fairchild R.B., Virgo K.S., Johnson F.E. Major hepatic resection. Indications and results in a national hospital system from 1998 to 1992. Arch Surg 1997; 132: 115-19.
  26. Wayne J.D., Lauwers G.Y., Ikai I., et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 2002; 235: 722-31.
  27. Fong Y., Sun R.L., Jarnagin W., Blumgart L.H. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790-99.
  28. Schwartz M., Roayaie S., Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 2007; 4(7): 424-32.
  29. Hasegawa K., Kokudo N., Imamura H., et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005; 242: 252-59.
  30. Ng K.K., Vauthey J.N., Pawlik T.M., et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multiinstitutional database. Ann Surg Oncol 2005; 12: 364-73.
  31. Samuel D., Colombo M., El Serag H. What is ago al. that transplantation should a chievein the contex to the patocellular carcinoma? Proceedings of the 2010 International Consensus Conference on Liver transplantation for HCC., 2 -4 December 2010.
  32. Jonas S., Bechstein W.O., Steinmuller T., et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-86.
  33. Montorsi M., Santambrogio R., Bianchi P., et al. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 2005; 9: 62-7.
  34. Capussotti L., Muratore A., Amisano M., et al. Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival-a European single center experience. EJSO 2005; 31, 986-93.
  35. Nuzzo G., Giuliante F., Gauzolino R., et al. Liver resections for hepatocellular carcinoma in chronic liver disease: experience in an Italian centre. Eur J Surg Oncol 2007; 33: 1014-18.
  36. Margarit C., Charc R., Hidalgo G., et al. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 2002; 2 6: 257-63.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies